Category Innovation/ R&D

US Supreme Court Restricts Gene Patents … A Little

Last Thursday, the United States Supreme Court overturned more than 30 years of precedents and ruled that isolated genes cannot be patented. They are products of nature and thus not patent-eligible subject matter, the court unanimously held in Assoc. for Molecular Pathology v. Myriad Genetics, Inc. This ruling puts the US at odds with most other nations, which allow genes to be patented. But because other major nations grant narrower gene patents, the net effect of Myriad will be to shift the US position on gene patents closer to that of other nations.

Test Of Political Flexibility In Final Lap For WIPO Treaty For The Blind

Starting next week, Marrakesh, Morocco, will be the site of a two-week high level conference expected to yield a treaty facilitating the international access to books for blind and visually impaired people. Stakes are high, not only for the beneficiaries, but also for the industry worried that the copyright system might be endangered by the new treaty, introducing limitations to copyright.

To What Extent Can Global IP Rules Be Responsive To Public Interest Demands? The Case Of The Treaty For The Visually Impaired

To what extent can global intellectual property rules address in an effective manner the needs of the most vulnerable members of society? This is the key question with which member states of the World Intellectual Property Organization (WIPO) are faced as they prepare to meet next week for a diplomatic conference, in Marrakesh, that should result in the adoption of a treaty to facilitate access to copyrighted works by visually impaired persons and persons with print disabilities.

UN Human Rights Council Adopts Resolution Promoting Medicines Access

The United Nations Human Rights Council today adopted a resolution urging governments to encourage technology development and transfer and to apply intellectual property rights measures in ways that avoid creating barriers to trade in “affordable, safe, efficacious and quality medicines.” The resolution includes references to IP flexibilities in international trade law and to “delinkage” of R&D costs with the price of health products.

WHO Updates Guidance For Pandemic Flu Risk Management

The World Health Organization (WHO) has released an updated guidance document on pandemic influenza risk management, which includes the Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits that was discussed by member states during the 66th World Health Assembly (WHA) in May.

WTO TRIPS Council: Discussion Of Innovation Shows Divergent Views; Tobacco Back On Agenda

The impact of intellectual property rights on the transfer of ‘green’ technology was brought up to the World Trade Organization committee on intellectual property this week with divided points of view. In addition, a discussion on cost-effective innovation was criticised by some developing countries as side-tracking the committee's objectives, and the European Union's planned revision of its tobacco products directive was disapproved by some producer countries.

WTO Members Agree On Draft Extension Of TRIPS Transition For LDCs

World Trade Organization members today reached a draft decision on a request put forward by least-developed countries to extend the period during which they do not have to comply with international rules of intellectual property rights protection, according to sources. Under the terms of the hard-fought decision, LDCs can benefit from an extension of eight more years.